Bleichroeder LP Amends Stake in Scientific Industries

Ticker: SCND · Form: SC 13D/A · Filed: Nov 13, 2024 · CIK: 87802

Scientific Industries Inc SC 13D/A Filing Summary
FieldDetail
CompanyScientific Industries Inc (SCND)
Form TypeSC 13D/A
Filed DateNov 13, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.05
Sentimentneutral

Sentiment: neutral

Topics: ownership-change, sec-filing, amendment

Related Tickers: SCIN

TL;DR

Bleichroeder LP updated their 13D filing for Scientific Industries Inc. on 11/13/24.

AI Summary

Bleichroeder LP filed an amendment (SC 13D/A) on November 13, 2024, regarding their holdings in Scientific Industries, Inc. The filing indicates a change in their beneficial ownership as of October 31, 2024. Bleichroeder LP is a Delaware-incorporated entity with its principal business address in New York, NY.

Why It Matters

This amendment to a Schedule 13D filing signals a potential shift in significant ownership or strategy for Scientific Industries, Inc., which could impact its stock price and corporate direction.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and strategic shifts for the company.

Key Numbers

  • 11/13/2024 — Filing Date (Date of the SC 13D/A amendment filing)
  • 10/31/2024 — Event Date (Date of the event requiring the filing)

Key Players & Entities

  • Bleichroeder LP (company) — Filing entity
  • Scientific Industries, Inc. (company) — Subject company
  • 1345 Avenue of the Americas, 47th Floor, New York, New York 10105 (address) — Bleichroeder LP business address
  • 70 Orville Dr, Airport International Plz, Bohemia, NY 11716 (address) — Scientific Industries, Inc. business address

FAQ

What specific changes in beneficial ownership are detailed in this SC 13D/A filing?

The provided text is a header and does not contain the specific details of the ownership change, only that an amendment was filed by Bleichroeder LP concerning Scientific Industries, Inc. on 11/13/2024, with an event date of 10/31/2024.

Who is the subject company of this filing?

The subject company is Scientific Industries, Inc.

Who is the entity filing this amendment?

The entity filing this amendment is Bleichroeder LP.

What is the CUSIP number for Scientific Industries, Inc. common stock?

The CUSIP number for Scientific Industries, Inc. common stock is 808757108.

What is the primary business of Scientific Industries, Inc. according to the filing?

Scientific Industries, Inc. is in the 'Laboratory Analytical Instruments' sector, SIC code 3826.

Filing Stats: 916 words · 4 min read · ~3 pages · Grade level 8.5 · Accepted 2024-11-13 17:17:07

Key Financial Figures

  • $0.05 — Inc. (Name of Issuer) Common Stock, $0.05 par value (Title of Class of Securiti

Filing Documents

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer

(a) is hereby amended and restated as follows

Item 5 (a) is hereby amended and restated as follows: (a) As of the date of this Amendment, the Reporting Persons beneficially own 2,465,026 Shares, representing 20.95% of the outstanding Shares (including Shares that will be issuable upon the exercise of the Warrants). The percentages used herein are based upon (i) the 10,503,599 Shares reported as outstanding as of August 13, 2024 by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 14, 2024 and (ii) the 1,261,675 Shares issuable upon the exercise of the Warrants. SIGNATURE After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned, severally and not jointly, certifies that the information set forth in this statement is true, complete and correct. Dated: November 13, 2024 BLEICHROEDER LP By: /s/ Michael M. Kellen Name: Michael M. Kellen Title: Chairman and CO-CEO BLEICHROEDER HOLDINGS LLC By: /s/ Michael M. Kellen Name: Michael M. Kellen Title: Chairman and CO-CEO The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.